Top

International Urology and Nephrology

Published in:

01-11-2016 | Urology - Original Paper

Vitamin D₃ deficiency is associated with female sexual dysfunction in premenopausal women

Authors: Masum Canat, Lütfi Canat, Feyza Yener Öztürk, Hatice Eroğlu, Hasan Anıl Atalay, Yüksel Altuntaş

Published in: International Urology and Nephrology | Issue 11/2016

Abstract

Purpose

To assess female sexual functions in women who were affected by vitamin D₃ deficiency.

Methods

A total of 50 women with FSD and 58 healthy women controls were included in the study, according to the Female Sexual Function Index (FSFI) questionnaire using a 26.55 cutoff value. Detailed medical histories were obtained from all sexual active women, and all women were evaluated in terms of possible presence of depression with the Beck Depression Inventory (BDI). Serum 25-hydroxyvitamin D₃, follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin, total and free testosterone, estradiol, dehydroepiandrosterone-SO₄ (DHEA-SO₄), sex hormone-binding globulin (SHBG), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) levels were measured.

Results

Mean age of premenopausal women was 34.9 ± 6.3 years. The level of serum 25-hydroxyvitamin D₃ was significantly lower in women with FSD compared with the controls (15.9 ± 8.4 and 26.3 ± 11.7 nmol/L, respectively). Desire (p = 0.0001), arousal (p = 0.0001), lubrication (p = 0.002), orgasm (p = 0.0001), satisfaction (p = 0.018), and pain (p = 0.010) domain scores were also correlated with the levels of serum 25-hydroxyvitamin D₃. The BDI score showed a significant negative correlation with the total FSFI score (r = −0.492, p = 0.0001). The FSFI score not showed a significant correlation with the hormones (p > 0.05).

Conclusion

There is a relationship with FSD and deficiency of vitamin D₃. Also, increased depressive symptoms were associated with FSD.

Bargiota A, Dimitropoulos K, Tzortzis V, Koukoulis GN (2011) Sexual dysfunction in diabetic women. Hormones (Athens) 3:196–206CrossRef

Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E (2004) The prevalance of female sexual dysfunction and potential risk factors that may impair sexual dysfunction in Turkish woman. Urol Int 72:52–57CrossRefPubMed

Salonia A, Zanni G, Nappi RE, Briganti A, Deho F, Fabbri F, Colombo R, Guazzoni G, Di Girolamo V, Rigatti P, Montorsi F (2004) Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a crosssectional study. Eur Urol 45:642–648CrossRefPubMed

Basson R, Rees P, Wang R, Montejo AL, Incrocci L (2010) Sexual function in chronic illness. J Sex Med 7:374–388CrossRefPubMed

Berman JR, Bassuk J (2002) Physiology and pathophysiology of female sexual function and dysfunction. World J Urol 20:111–118CrossRefPubMed

Kadioglu P, Yalin AS, Tiryakioglu O, Gazioglu N, Oral G, Sanli O, Onem K, Kadioglu A (2005) Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol 174:1921–1925CrossRefPubMed

Atis G, Dalkilinc A, Altuntas Y, Atis A, Caskurlu T, Ergenekon E (2010) Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med 7:2583–2590CrossRefPubMed

Veronelli A, Mauri C, Zecchini B, Peca MG, Turri O, Valitutti MT, Dall’ Asta C, Pontiroli AE (2009) Sexual dysfunction is frequent in premenopausal women with diabetes, obesity, and hypothyroidism, and correlates with markers of increased cardiovascular risk. A preliminary report. J Sex Med 6:1561–1568CrossRefPubMed

Bhasin S, Enzlin P, Coviello A, Basson R (2007) Sexual dysfunction in men and women with endocrine disorders. Lancet 369:597–611CrossRefPubMed

10.

Atis G, Dalkilinc A, Altuntas Y, Atis A, Gurbuz C, Ofluoglu Y, Cil E, Caskurlu T (2011) Hyperthyroidism: a risk factor for female sexual dysfunction. J Sex Med 8:2327–2333CrossRefPubMed

11.

Dicken CL, Israel DD, Davis JB, Sun Y, Shu J, Hardin J, Neal-Perry G (2012) Peripubertal vitamin D(3) deficiency delays puberty and disrupts the estrous cycle in adult female mice. Biol Reprod 87(2):51CrossRefPubMedPubMedCentral

12.

Lerchbaum E, Obermayer-Pietsch B (2012) Vitamin D and fertility: a systematic review. Eur J Endocrinol 166(5):765–778CrossRefPubMed

13.

Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151(1):32–42CrossRefPubMed

14.

Halloran BP, DeLuca HF (1980) Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr 110(8):1573–1580PubMed

15.

Kwiecinksi GG, Petrie GI, DeLuca HF (1989) 1, 25-Dihydroxyvitamin D₃ restores fertility of vitamin D-deficient female rats. Am J Physiol 256:483–487

16.

Sun W, Xie H, Ji J, Zhou X, Goltzman D, Miao D (2011) Defective female reproductive function in 1, 25(OH)2D-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus. Am J Physiol Endocrinol Metab 299:928–935CrossRef

17.

Johnson LE, DeLuca HF (2002) Reproductive defects are corrected in vitamin ddeficient female rats fed a high calcium, phosphorus and lactose diet. J Nutr 132(8):2270–2273PubMed

18.

Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y (2000) Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141(4):1317–1324PubMed

19.

Yoshizawa T, Handa Y, Uematsu Y et al (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16(4):391–396CrossRefPubMed

20.

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281CrossRefPubMed

21.

Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208CrossRefPubMed

22.

Cayan F, Dilek S, Akbay E, Cayan S (2008) Sexual function after surgery for stress urinary incontinence: vaginal sling versus Burch colposuspension. Arch Gynecol Obstet 277:31–36CrossRefPubMed

23.

Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20CrossRefPubMed

24.

Turunc T, Deveci S, Guvel S, Peskircioglu L (2007) The assessment of Turkish validation with 5 question version of ınternation index of erectile function (IIEF-5). Turk J Urol 33:45–49

25.

Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326CrossRefPubMed

26.

Onem K, Erol B, Sanli O, Kadioglu P, Yalin AS, Canik U, Cuhadaroglu C, Kadioglu A (2008) Is sexual dysfunction in women with obstructive sleep apnea-hypopnea syndrome associated with the severity of the disease? A pilot study. J Sex Med 5:2600–2609CrossRefPubMed

27.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed

28.

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114(10):577–583CrossRefPubMed

29.

Shifren JL (2004) The role of androgens in female sexual dysfunction. Mayo Clin Proc 79(Suppl 4):19–24

30.

Sherwin BB, Gelfand MM, Brender W (1985) Androgen enhances sexualmotivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 47:339–351CrossRefPubMed

31.

Davis S, McCloud P, Strauss B, Burger H (1996) Testosterone enhancesestradiol’s effects on postmenopausal bone density and sexuality. Maturitas 21:227–236CrossRef

32.

Zanatta L, Zamoner A, Zanatta AP, Bouraima-Lelong H, Delalande C, Bois C, Carreau S, Silva FR (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D₃ in rat testis. Life Sci 89:515–523CrossRefPubMed

33.

Hofer D, Munzker J, Schwetz V, Ulbing M, Hutz K, Stiegler P, Zigeuner R, Pieber TR, Müller H, Obermayer-Pietsch B (2014) Testicular synthesis and vitamin D action. J Clin Endocrinol Metab 99(10):3766–3773CrossRefPubMed

34.

Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T, GSSAB Investigators’ Group (2005) Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 17:39–57CrossRefPubMed

35.

Oksuz E, Malhan S (2006) Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 175:654–658CrossRefPubMed

36.

Clayton AH (2007) Epidemiology and neurobiology of female sexual dysfunction. J Sex Med 4(Suppl. 4):260–268CrossRefPubMed

37.

Garcia S, Moreno S, Aponte H (2008) Prevalence of sexual dysfunction in female outpatients and personnel at a Colombian hospital: correlation with hormonal profile. J Sex Med 5:1208–1213CrossRefPubMed

38.

Davis SR, Guay AT, Shifren JL, Mazer NA (2004) Endocrine aspects of female sexual dysfunction. J Sex Med 1:82–86CrossRefPubMed

39.

Althof SE, Leiblum SR, ChevretMeasson M, Hartmann U, Levine SB, McCabe M, Plaut M, Rodrigues O, Wylie K (2005) Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2:793–800CrossRefPubMed

40.

Kadioglu P, Yetkin DO, Sanli O, Yalin AS, Onem K, Kadioglu A (2010) Obesity might not be a risk factor for female sexual dysfunction. BJU Int 106(9):1357–1361CrossRefPubMed

41.

Yaylali GF, Tekekoglu S, Akin F (2010) Sexual dysfunction in obese and overweight women. Int J Impot Res 22(4):220–226CrossRefPubMed

42.

Pasquali D, Maiorino MI, Renzullo A, Bellastella G, Accardo G, Esposito D, Barbato F, Esposito K (2013) Female sexual dysfunction in women with thyroid disorders. J Endocrinol Invest 36(9):729–733PubMed

43.

von Känel R, Fardad N, Steurer N, Horak N, Hindermann E, Fischer F, Gessler K (2015) Vitamin D deficiency and depressive symptomatology in psychiatric patients hospitalized with a current depressive episode: a factor analytic study. PLoS ONE 10(9):e0138550CrossRef

44.

Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF (2015) Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 227(1):46–51CrossRefPubMedPubMedCentral

45.

Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74(1):27–32CrossRefPubMed

Title: Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women
Authors: Masum Canat
Lütfi Canat
Feyza Yener Öztürk
Hatice Eroğlu
Hasan Anıl Atalay
Yüksel Altuntaş
Publication date: 01-11-2016
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 11/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-016-1396-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2016

Micafungin treatment and eradication of candiduria among hospitalized patients

Infective complications after retrograde intrarenal surgery: a new standardized classification system

A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms

Review of “The Nurse Practitioner in Urology”

Pre-dialysis renal clinic visits and patients’ outcomes on peritoneal dialysis

Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials